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34S Abstracts May Supplement 2013Conclusions: This largest study of IFAA demonstrates
that: 1. Acute complications did not occur in aneurysms
smaller than 3.5cm; repair criteria for asymptomatic FAA
should be changed to >3.5 cm 2. The presence of chronic
FAA thrombus should reduce the threshold for elective
repair. 3. Criteria for symptomatic FAA repair should
remain unchanged.
Author Disclosures: C. J. Abularrage: Nothing to
disclose; S. S. Ahn: Nothing to disclose; J. L. Ballard:
Nothing to disclose; P. Flanigan: Nothing to disclose;
M. P. Harlander-Locke: Nothing to disclose; N.
Hedayati: Nothing to disclose; M. D. Humphries:
Nothing to disclose; G. J. Landry: Nothing to disclose;
P. F. Lawrence: Nothing to disclose; B. Mendes: Nothing
to disclose; M. Mueller: Nothing to disclose; G. S. Oder-
ich: Nothing to disclose;W. C. Pevec: Nothing to discloseVS6.
Video Presentation
Trans-Catheter Aortic Valve Replacement Access,
Complications, and Bailouts
Manish Mehta1, Augustin J. Delago3, Edward V. Bennett2,
Lewis W. Britton2, Mohammed C. El-Hajjar2,
R. Clement Darling1, Philip S. Paty1, Yaron Sternbach1.
1The Vascular Group, The Institute for Vascular Health
and Disease, Albany Medical College, The Center for
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Center Hospital, Albany Medical College, Albany, NY;
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Background: Transcatheter aortic valve replacement
(TAVR) has revolutionized treatments for patients with
severe symptomatic aortic valve stenosis. In 2011 FDA
approved TAVR for surgically inoperable patients, and in
2012 for surgical high risk patients. Currently randomized
trials are underway evaluating the efﬁcacy of TAVR for
surgical low risk patients. Similar to TEVAR, TAVR
requires navigation of 22-25Fr sheaths and catheters across
the aortoiliac segments and expose patients to the risks of
arterial injury, bleeding, and stroke. As vascular surgeons
we have participated in nearly 100 TAVR procedures, and
can attest to the importance of vascular surgeons involve-
ment in not only limiting patient risks, but also in expanding
the indications for patients with critical aortic stenosis and
no other treatment options, as well as in managing bailouts
following complications of these procedures.
Technical Description: This video presentation will
focus on the implications of appropriate access during
TAVR. Tips and tricks to the bailout procedures needed
during misplaced aortic valves that require retrieval, as
well as diagnosis and treatments for arterial injury during
trans-femoral and trans-apical TAVR.
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Management of Acute Limb Ischemia in the Pediatric
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Objectives: Acute limb ischemia (ALI) in pediatric
patients is rare but may lead to limb loss and life-long
complications. The aim of this study was to review the
experience of a Canadian tertiary pediatric center with
the medical and operative management of ALI.
Methods: The charts of in-patients diagnosed with
acute upper or lower limb ischemia between 1999-2012
were reviewed. Patient demographics, arterial clot site and
etiology, intervention, anticoagulation type and duration,
and short and long-term complications were analyzed.
Results: 136 patients presented with signs of limb
ischemia (46% female, 34% younger than 30 days, 51%
between 1-12 months, and 15% between 1-18 years). 95%
involved the lower limbs. 85% of arterial clots were totally
occlusive. 92% were due to vessel catheterization, 5% were
idiopathic, and 2% were due to hereditary hypercoagulable
states. 96% were managed nonoperatively. Patients were
treated with a combination of thrombolysis, unfractionated
or low molecular-weight heparin, aspirin and/or warfarin
(duration, 1 day-13 years). All patients were followed postdi-
scharge at our institution or at their referring hospital (average,
3.5 years). 13%had complications related toALIor anticoagu-
lation (limb length or thigh circumference discrepancy, or
intracranial hemorrhage). 25 patients died of unrelated causes
(sepsis, multi-organ dysfunction, or cardiac failure).
Conclusions: In contrast with adults, ALI in children
can generally be managed nonoperatively with anticoagula-
tion, likely because of their greater ability to develop arte-
rial collaterals. Long-term follow-up by a multidisciplinary
team of pediatric and surgical specialists and allied health
professionals is integral to achieving a successful outcome.
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The Positive Effect of Reentry Device With
Intravascular Ultrasound on Technical Success, Safety
and Patency of Subintimal Angioplasty of Chronic
Total Occlusion in Iliac Arteries
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Objectives: Review impact of reentry devices (RED)
on subintimal angioplasty (SIA) of iliac artery chronic total
occlusion (CTO).
Methods: We completed a retrospective review of iliac
artery CTO treated with SIA from 2003 to 2012.
Results: From 1100 iliac interventions, 214 SIA of
iliac CTOs were identiﬁed: 72 in the RED group, 36
IVUS directed RED group. The mean age was 63 years,
males 59%, TASC B 27%, C 36% and D 37%. IVUS
directed RED had a larger proportion of TASC D lesions
compared to the non-RED group (58% vs 36%; P ¼
.01). Indications included claudication (66%) and CLI
(34%). Clinical proﬁle and indications were not different
between groups.
Technical success was 92%, with a trend towards higher
technical success with a RED vs non-RED (96% vs 90%; P
¼ .1).
The overall incidence of retrograde aortoiliac dissec-
tions that required treatment was 13% and compared to
the non-RED group, the IVUS directed RED group had
a lower incidence (3% vs 14%; P ¼ .06).
The overall incidence of retrograde aortic dissections
that required treatment was 8% and compared to the
non-RED group, the non-IVUS-directed RED group
had a higher incidence (17% vs 6%; P ¼ .04).
Retroperitoneal hematoma from unrecognized iliac
injury occurred in 5 cases (2.5%). Compared to the one
case in the non-RED group, there was one case in the
IVUS-directed RED group (3% vs 1%; P ¼ .4), and
three cases in the non-IVUS-directed RED (8% vs 1%;
P ¼ .03).
Primary patency for the RED group vs the non-RED
group at 1 and 3 years was 87% and 75% vs 73% and
59% respectively, with the use of a RED having a positive
effect on primary patency based on multivariate analysis
(HR, 0.4; P ¼ .03). Secondary patency for the RED group
vs the non-RED group at 3 years was 87% vs 79 % and was
not statistically different (P ¼ .8).
Conclusions: Reentry devices can improve technical
success and primary patency of SIA recanalization of iliac
artery CTO. IVUS directed reentry may further enhance
the safety of the procedure.
Author Disclosures: S. Ahanchi: Nothing to disclose; D.
Dexter: Nothing to disclose; J. Kim: Nothing to disclose;
T. Massimi: Nothing to disclose; J. Panneton: Medtronic,
Consulting fees or other remuneration (payment) spectro-
netics, Consulting fees or other remuneration (payment);
A. Teng: Nothing to disclose.SS28.
Health Care Associated Infections After Lower
Extremity Revascularization
Alireza Daryapeyma1, Ollie Östlund2, Carl Wahlgren1.
1Karolinska Institute, Stockholm, Sweden; 2Uppsala
University, Uppsala, SwedenObjectives: To elucidate the incidence of health care
associated infections and related risk factors in elective
lower extremity vascular interventions.
Methods: A retrospective nationwide survey of all
postoperative infections among patients who have under-
gone elective open and endovascular surgery for lower
extremity arterial disease between 2005 and 2010 (n ¼
10547). Data were retrieved from the National vascular
surgery registry and cross-matched with the National
patient and cause of death registries.
Results: Patients (claudication 27%; critical limb
ischemia (CLI) 17% and gangrene 56%) were treated
with endovascular intervention (n ¼ 6262; 59%), throm-
bendarterectomy (TEA) (n ¼ 1061; 10%), or bypass
surgery (n ¼ 3224; 31%). The total incidence of postoper-
ative infection (<30-d) was 9.7%. Skin and soft tissue infec-
tion (n ¼ 735; 6.9%), including surgical site infection and
graft infection dominated. This was followed by urinary
tract infection (n ¼ 168; 1.6%), pneumonia (n ¼ 114;
1.1%) and sepsis (n ¼ 91; 0.9%). Infection was signiﬁcantly
associated with both operative method and indication for
treatment (TEA vs Endo in claudicants [OR 6.7 (95% CI
3.9-11.6]) and CLI [OR 2.0 (95% CI 1.1-3.7)]; Bypass
vs Endo in claudicants [OR 8.4 (95% CI 5.0-14)] and
CLI [OR 3.4 (95% CI 2.3-5.1)]. Risk factors associated
with infection were diabetes, renal insufﬁciency, heart and
lung disease (P < .05). There was a signiﬁcant increase in
the 1-year amputation rate (11.8% vs 5.6%) and 30-day
mortality (4.2% vs 2.5%) for patients with postoperative
infection within 30 days (P < .001).
Conclusions: The risk of infection varies depending
on method of treatment and the extent of comorbidities.
Open surgery in claudicants confers a 7-fold increased
risk compared to endovascular treatment. Early postopera-
tive infection is signiﬁcantly associated with an increased
rate of amputation and mortality.
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Objectives: Open surgical repair (OSR) for chronic
Type B aortic dissections (CTBAD) has an associated
morbidity and mortality. The role of thoracic endovascular
aneurysm repair (TEVAR) in CTBAD has not been deter-
mined. We analyzed our contemporary experience of
CTBAD undergoing OSR to identify high-risk patients
that may be considered for TEVAR.
Methods: From 1999-2010, 221 patients had repair
of descending thoracic and thoracoabdominal aortic
